These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26404127)

  • 1. Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
    Tjalma WA
    J Gynecol Oncol; 2015 Oct; 26(4):355-6. PubMed ID: 26404127
    [No Abstract]   [Full Text] [Related]  

  • 2. Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
    Tjalma WA
    Eur J Gynaecol Oncol; 2016; 37(1):5. PubMed ID: 27048100
    [No Abstract]   [Full Text] [Related]  

  • 3. Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
    Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():207. PubMed ID: 26589439
    [No Abstract]   [Full Text] [Related]  

  • 4. Staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J;
    Int J Gynaecol Obstet; 2014 Jan; 124(1):1-5. PubMed ID: 24219974
    [No Abstract]   [Full Text] [Related]  

  • 5. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer.
    Seidman JD; Zhao P; Yemelyanova A
    Gynecol Oncol; 2011 Mar; 120(3):470-3. PubMed ID: 21159368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO).
    Prat J;
    Obstet Gynecol; 2015 Jul; 126(1):171-4. PubMed ID: 26241270
    [No Abstract]   [Full Text] [Related]  

  • 7. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J;
    Eur J Obstet Gynecol Reprod Biol; 2015 May; 188():133-5. PubMed ID: 25819291
    [No Abstract]   [Full Text] [Related]  

  • 8. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
    Morrison JC; Blanco LZ; Vang R; Ronnett BM
    Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
    Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
    Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.
    Prat J;
    J Gynecol Oncol; 2015 Apr; 26(2):87-9. PubMed ID: 25872889
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early adenocarcinoma of the fallopian tubes. A case for multifocal tumorigenesis.
    Bannatyne P; Russell P
    Diagn Gynecol Obstet; 1981; 3(1):49-60. PubMed ID: 7215124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-reducing salpingectomy as a new and safe strategy to prevent ovarian cancer.
    Morelli M; Venturella R; Zullo F
    Am J Obstet Gynecol; 2013 Oct; 209(4):395-6. PubMed ID: 23665245
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: To PMID 23583217.
    Erickson BK; Landen CN; Conner MG
    Am J Obstet Gynecol; 2013 Oct; 209(4):396. PubMed ID: 23665249
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma in situ of the fallopian tube presenting as a positive Pap smear.
    Safret A; Bösch B; Bannwart F; Rinderknecht B; Hafner HU
    Acta Cytol; 2004; 48(3):462-4. PubMed ID: 15192974
    [No Abstract]   [Full Text] [Related]  

  • 17. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J; Belhadj H; Berek J; Bermudez A; Bhatla N; Cain J; Denny L; Fujiwara K; Hacker N; Avall-Lundqvist E; Mutch D; Odicino F; Pecorelli S; Quinn M; Seoud MA; Shrivastava SK;
    Eur J Gynaecol Oncol; 2015; 36(4):367-9. PubMed ID: 26390684
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 2():S111-22. PubMed ID: 26433667
    [No Abstract]   [Full Text] [Related]  

  • 19. Tu-be or not tu-be: that is the question… about serous ovarian carcinogenesis.
    Chene G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):134-43. PubMed ID: 23523591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.
    Prat J
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.